U.S. & Israeli Innovations in the Life Sciences: Part 2
Tuesday, March 2, 2021
12:00 – 1:00 pm ET
Join attorneys, scientists, investors, entrepreneurs, and the Jewish National Fund community for an exclusive panel discussion with industry experts from the BioTech and Pharmaceutical sectors of Israel and Miami.
Hear about the potential COVID-19 “cure” Allocetra developed by Enlivex Therapeutics from Chief Scientific & Medical Officer Dror Mevorach during an intimate fireside chat.
The program will also include a lively discussion with a Miami & Israeli BioTech Panel featuring Isaac Litman, Founder & CEO of Neteera Technologies, Dr. Osnat Sela Tavor, CTO of Nanose Medical, and Andrew Satz, CEO of EVQLV, moderated by Meital Stavinsky, Partner at Holland & Knight. As part of the day’s program, learn about Jewish National Fund’s latest food technology endeavor from Nathan Hoffman, CEO of the upcoming Galilee Culinary Institute by JNF.
Partner, Holland & Knight
Co-Chair of Israel Practice
Fireside Chat on COVID-19 Cure
Professor Dror Mevorach
Chief Scientific and Medical Officer, Enlivex Therapeutics
Director Rheumatology Research Center & Chairman of Medicine, Hadassah Medical Center in Jerusalem
Miami/Israel BioTech Panel
Dr. Osnat Sela Tavor
Jewish National Fund Food Tech Update
CEO, Galilee Culinary Institute by JNF
Thank You To Our Sponsor
Mr. Ronald Gerstl
Author of The Super Achievers: The Remarkable Jewish Contribution to Science and Human Well-being Highlighted by Nobel Prize Winners
Additional sponsorship opportunities available.
Mike Teichberg, Director, Miami-Dade
[email protected] or 305.682.0025 x897